APA Alıntı

Gooden, M. J. M., Wiersma, V. R., Boerma, A., Leffers, N., Boezen, H. M., ten Hoor, K. A., . . . Bremer, E. (2014). Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity. Nature Publishing Group.

Chicago Stili Alıntı

Gooden, M J M., et al. Elevated Serum CXCL16 Is an Independent Predictor of Poor Survival in Ovarian Cancer and May Reflect Pro-metastatic ADAM Protease Activity. Nature Publishing Group, 2014.

MLA Alıntı

Gooden, M J M., et al. Elevated Serum CXCL16 Is an Independent Predictor of Poor Survival in Ovarian Cancer and May Reflect Pro-metastatic ADAM Protease Activity. Nature Publishing Group, 2014.